Biovitrum AB and Pharmacopeia form strategic drug discovery and development alliance

02-Nov-2004 - Stockholm and Princeton. Biovitrum AB and Pharmacopeia Drug Discovery, Inc. announced that they have entered into a multi-year drug discovery and development alliance. Biovitrum and Pharmacopeia will work together to identify and optimise small molecule lead compounds suitable for advancing into ...

AVI BioPharma and USAMRIID Announce NeuGene Antisense Drug Demonstrates Efficacy Against Ebola Virus

02-Nov-2004 - AVI BioPharma, Inc. , and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) announced positive results from experiments testing the effect of AVI's NeuGene® antisense drugs against Ebola virus (EBOV) in vivo. The NeuGene compounds targeted several EBOV genes. These ...

Oxford BioMedica and ARIUS Research Extend Collaboration on Novel Cancer Targets

Success of initial stage leads to further two-year partnership

01-Nov-2004 - Oxford BioMedica and ARIUS Research Inc. announced the first milestone and their decision to move into the next phase of their collaboration to discover and characterise novel cancer targets and downstream therapeutic products. Under the agreement, antigen targets and antibodies can be ...

Microdosing and human drug absorption studies under the spotlight in live web cast

29-Oct-2004 - Strategies to improve decision-making in early drug development will be under the spotlight on November 4th 2004 when one of the industry's leading early phase specialists hosts a web-based discussion and presentation. The on-line sessions have been designed by Pharmaceutical ...

BioAlliance announces improved anti-fungal drug exposure publication

27-Oct-2004 - Paris. BioAlliance Pharma announced that a research team, including the company, reported results demonstrating the potential superiority of a new formulation of miconazole administered as a bioadhesive extended release buccal tablet compared to the same drug applied in a topical gel for ...

Generating Pharmaceutical Sales before Marketing Authorization

27-Oct-2004 - Amsterdam. When a patient has a serious illness and there is no approved drug available, the physician may want to try one which has not been authorized for marketing by national health authorities but has shown promise in clinical trials. European Named Patient Programs, like US compassionate ...

ComGenex Inc. and Echelon Biosciences Inc. Expand Their Drug Discovery Collaboration

26-Oct-2004 - Budapest and Salt Lake City. ComGenex Inc. and Echelon Biosciences Inc. announced the extension and expansion of their drug discovery and development collaboration. Both companies have benefited from this productive two-year relationship. ComGenex has provided Echelon with proprietary small ...

Astex achieves drug discovery collaboration success with Schering AG

25-Oct-2004 - Cambridge, UK. Astex Technology announced that it has completed a significant goal in its multi-target drug discovery collaboration with Schering AG. Financial terms were not disclosed. The collaboration was announced in May 2003 and is a four-year, multi-target based alliance for the discovery ...

ClinPhone wins Sage Business Award

22-Oct-2004 - ClinPhone Group, the global leader in clinical technology solutions, has won the 2004 Sage Business Awards in the Best Growth Through Technology category for companies with more than 100 members of staff. The Best Growth Through Technology Award is given to the company demonstrating the best ...

OctoPlus and InnoCore to partner on a novel drug delivery platform for peptides and small molecules

22-Oct-2004 - Leiden / Groningen. OctoPlus, a drug delivery and development company and InnoCore Technologies BV, a supplier of biodegradable polymeric drug delivery systems, announced today that they have entered into a collaboration to develop and market a novel injectable drug delivery platform. This ...